Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial

ME Gore, CL Griffin, B Hancock, PM Patel, L Pyle, M Aitchison, Nicholas James, RTD Oliver, J Mardiak, T Hussain, R Sylvester, MKB Parmar, P Royston, PFA Mulders

Research output: Contribution to journalArticle

88 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science